These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19366711)

  • 21. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ; Stein KM; Markowitz SM; Mittal S; Shah BK; Morin DP; Zacks ES; Janik M; Ageno S; Mauer AC; Lerman BB; Iwai S
    J Am Coll Cardiol; 2007 Jul; 50(2):166-73. PubMed ID: 17616302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
    Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital readmission in patients with implantable cardioverter-defibrillators.
    Kaźmierczak J; Zielonka J; Rzeuski R; Peregud-Pogorzelska M; Goracy J; Biernawska J; Sulikowski T; Kornacewicz-Jach Z
    Kardiol Pol; 2006 Jul; 64(7):684-91; discussion 692-3. PubMed ID: 16886125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal insufficiency predicts the time to first appropriate defibrillator shock.
    Hreybe H; Ezzeddine R; Bedi M; Barrington W; Bazaz R; Ganz LI; Jain S; Ngwu O; London B; Saba S
    Am Heart J; 2006 Apr; 151(4):852-6. PubMed ID: 16569548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
    Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
    Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.
    Hreybe H; Razak E; Saba S
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1091-5. PubMed ID: 17725751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
    Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
    Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
    Petrović D; Obrenović R; Stojimirović B
    Clin Lab; 2008; 54(5-6):145-52. PubMed ID: 18780659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical risk score to predict the time to first appropriate device therapy in recipients of implantable cardioverter defibrillators.
    Hreybe H; Saba S
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):385-9. PubMed ID: 17367358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
    Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function.
    Rönn F; Kesek M; Höglund N; Jensen SM
    Scand Cardiovasc J; 2008 Apr; 42(2):125-9. PubMed ID: 18365895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle.
    Borleffs CJ; Scherptong RW; Man SC; van Welsenes GH; Bax JJ; van Erven L; Swenne CA; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):548-54. PubMed ID: 19843923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
    Albert CM; Quigg R; Saba S; Estes NA; Shaechter A; Subacius H; Howard A; Levine J; Kadish A;
    Am Heart J; 2008 Aug; 156(2):367-72. PubMed ID: 18657670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction.
    Cook G; Taylor D; France M; Burrows G; Manning E; Lyratzopoulos G; McElduff P; Lewis P; Martin M; Heller RF
    QJM; 2005 Apr; 98(4):275-82. PubMed ID: 15760923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.